Connor, Clark & Lunn Investment Management (CC&L)’s Elanco Animal Health ELAN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.99M | Buy |
+279,124
| New | +$3.99M | 0.01% | 648 |
|
|
2025
Q1 | – | Sell |
-53,830
| Closed | -$652K | – | 1465 |
|
|
2024
Q4 | $652K | Buy |
+53,830
| New | +$652K | ﹤0.01% | 1073 |
|
|
2024
Q1 | – | Sell |
-388,459
| Closed | -$5.79M | – | 1565 |
|
|
2023
Q4 | $5.79M | Sell |
388,459
-58,888
| -13% | -$877K | 0.03% | 383 |
|
|
2023
Q3 | $5.03M | Sell |
447,347
-52,045
| -10% | -$585K | 0.03% | 401 |
|
|
2023
Q2 | $5.02M | Buy |
499,392
+218,476
| +78% | +$2.2M | 0.03% | 400 |
|
|
2023
Q1 | $2.64M | Buy |
+280,916
| New | +$2.64M | 0.01% | 498 |
|
|
2020
Q4 | – | Sell |
-51,723
| Closed | -$1.45M | – | 937 |
|
|
2020
Q3 | $1.45M | Buy |
+51,723
| New | +$1.45M | 0.01% | 542 |
|
|
2019
Q3 | – | Sell |
-33,000
| Closed | -$1.12M | – | 989 |
|
|
2019
Q2 | $1.12M | Buy |
33,000
+500
| +2% | +$16.9K | 0.01% | 547 |
|
|
2019
Q1 | $1.04M | Buy |
+32,500
| New | +$1.04M | 0.01% | 526 |
|